Mostrar el registro sencillo del ítem

dc.contributor.authorDeandrea, S.
dc.contributor.authorMolina Barceló, A.
dc.contributor.authorUluturk, A.
dc.contributor.authorMoreno, J.
dc.contributor.authorNeamtiu, L.
dc.contributor.authorPeiró Pérez, R.
dc.contributor.authorSaz Parkinson, Z.
dc.contributor.authorLópez Alcalde, Jesús 
dc.contributor.authorLerda, D.
dc.contributor.authorSalas, D.
dc.date.accessioned2017-03-24T11:59:58Z
dc.date.available2017-03-24T11:59:58Z
dc.date.issued2016-08-13
dc.identifier.issn0091-7435
dc.identifier.urihttp://hdl.handle.net/10641/1279
dc.description.abstractThe European Union Council Recommendation of 2 December 2003 on cancer screening suggests the implementation of organised, population-based breast cancer screening programmes based on mammography every other year for women aged 50 to 69 years, ensuring equal access to screening, taking into account potential needs for targeting particular socioeconomic groups. A European survey on coverage and participation, and key organisational and policy characteristics of the programmes, targeting years 2010 and 2014, was undertaken in 2014. Overall, 27 countries contributed to this survey, 26 of the 28 European Union member states (92.9%) plus Norway. In 2014, 25 countries reported an ongoing population-based programme, one country reported a pilot programme and another was planning a pilot. In eight countries, the target age range was broader than that proposed by the Council Recommendation, and in three countries the full range was not covered. Fifteen countries reported not reaching some vulnerable populations, such as immigrants, prisoners and peoplewithout health insurance, while 22 reported that participation was periodically monitored by socioeconomic variables (e.g. age and territory). Organised, population-based breast cancer screening programmes based on routine mammograms are in place in most EU member states. However, there are still differences in the way screening programmes are implemented, and participation by vulnerable populations should be encouraged.spa
dc.language.isoengspa
dc.publisherPreventive Medicinespa
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.subjectCáncerspa
dc.subjectDetección precozspa
dc.subjectNeoplasia mamariaspa
dc.subjectEuropaspa
dc.titlePresence, characteristics and equity of access to breast cancer screening programmes in 27 European countries in 2010 and 2014. Results froman international survey.spa
dc.typearticlespa
dc.description.versionpost-printspa
dc.rights.accessRightsopenAccessspa
dc.description.extent1179 KBspa


Ficheros en el ítem

FicherosTamañoFormatoVer
2016-Deandrea-Preventive Medic ...1.150MbPDFVer/
license_rdf1.203Kbapplication/rdf+xmlVer/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial-SinDerivadas 3.0 España
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial-SinDerivadas 3.0 España